: ' Food and Drug Administration'

FDA Warns About “Natural” Painkiller

The U.S. Food and Drug Administration has issued a second warning about a “natural” dietary supplement being marketed for pain relief from arthritis. The agency says Reumofan Plus and Reumofan Plus Premium contain several potentially harmful [...]

FDA Warns of Children’s Deaths Linked to Codeine

Three children have died and one suffered a non-fatal, but life-threatening case of respiratory depression after taking the pain reliever codeine after surgery to remove their tonsils and/or adenoids.  As a result, the U.S. Food and [...]

Chemical in Soap Could Cause Health Problems

A chemical widely used in antibacterial soaps and other household products may impair heart and muscle function, and cause other harmful effects to both people and the environment, according to a new study by researchers at [...]

Off Label Drug Use is Common

Many patients may not realize they are being prescribed drugs “off-label” by their physician, according to an analysis by the Mayo Clinic. Off-label means a doctor prescribed a medication for treatment of a condition that has [...]

Smokers Switching to Cigars and Pipe Tobacco to Avoid Taxes

Smokers are turning to cigars and “roll your own” tobacco to avoid the high cost of cigarettes, according to a new report by the U.S. Center for Disease Control and Prevention. The decade-long trend has been [...]

FDA’s Painkiller Education Campaign Criticized

Two pain management physicians are criticizing plans by the Food and Drug Administration for a voluntary educational campaign for doctors on the risks and benefits of prescribing opioid painkillers. The FDA’s risk evaluation and mitigation strategy [...]

Living with Pain: PROP’s Misleading Petition

Last week the Physicians for Responsible Opioid Prescribing, along with a group of doctors and public health officials, sent a petition to the Food and Drug Administration requesting changes in labeling for opioid analgesics. For over [...]

New Addiction Treatment Drug Could Be Alternative to Suboxone

A Swedish pharmaceutical company says it will soon seek approval from the U.S. Food and Drug Administration for a new medication to treat opioid dependency. Two clinical trials have been completed on the drug, called OX219, [...]

Doctors Petition FDA to Limit Painkillers

Saying it was time to “close the loophole” on narcotic painkillers, a coalition of doctors and public health officials is petitioning the Food and Drug Administration to change the prescription guidelines for opioid medicines.  The move [...]

Nektar Begins Phase II Study of New Opioid

Nektar Therapeutics (NASDAQ: NKTR) has enrolled the first patient in a Phase II clinical study of a new opioid analgesic that is designed to enter the brain slowly, reducing the potential for the drug to be [...]